Sagene Pharmaceuticals, Inc. Announces FDA Approval of Clindamycin Injection, USP
10/3/2011 6:40:55 AM
More...
|
Sagene Pharmaceuticals, Inc. Completes Successful Pre-IND Meeting with FDA for Dual-Action Erectile Dysfunction Drug
9/9/2011 10:55:11 AM
More...
|
Sagene Pharmaceuticals, Inc. Prices IPO at $16 Per Share, Raises $92 Million in Gross Proceeds
4/20/2011 6:52:12 AM
More...
|